65th ASH Annual Meeting & Exposition: 902. Health Services and Quality Improvement – Lymphoid Malignancies: Improving Processes and Outcomes in Plasma Cell Dyscrasias

Symposia: Health Services and Quality Improvement - Lymphoid Malignancies Oral and Poster Abstracts
Oral

Research, Diversity, Equity, and Inclusion (DEI) , Diseases

Marriott Grand Ballroom 2-4 (Marriott Marquis San Diego Marina)

Moderators:

Edward R Scheffer Cliff, MBBS, MPH, Austin Health and Andrew J. Cowan, MD, Fred Hutchinson Cancer Research Center

Disclosures:

No relevant conflicts of interest to declare.

This session will focus on quality improvement initiatives and access to care for patients with plasma cell dyscrasias. The oral sessions examines how to streamline the work up for patients with Monoclonal Gammopathies, examines imaging modalities in myeloma, explores studies looking at improving access to care. We hope these oral abstracts all complement each other and provide insight in how to improve care for patients with plasma cell disorders.

3:00 PM

908

Primary Care Management Pathways to Reduce Wait Times in Hematology: Monoclonal Gammopathy of Undetermined Significance

Pallavi Ganguli, MD¹, Janique Dyba, MD, FRCPC¹^*, Annette E. Hay, MD, FRCPath, FRCPC¹, Liying Zhang, PhD²^*, Samuel A Silver, MD, MSc, FRCPC³^*, Yun Huang, PhD, FCACB⁴^*, Kevin Loughlin, MD, CCFP⁵^*, Elizabeth Eisenhauer, MD, FRCPC⁶^* and Bethany Elaine Monteith, MD, MSc, FRCPC⁷^*

¹Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada
²Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
³Division of Nephrology, Department of Medicine, Queen’s University, Kingston, ON, Canada
⁴Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada
⁵Maple Family Health Team, Kingston, ON, Canada
⁶Department of Oncology, Queen’s University, Kingston, ON, Canada
⁷Division of Hematology, Department of Medicine, Queen’s University, Kingston, ON, Canada

3:15 PM

909

A Randomized Controlled Trial of a Financial Navigation Program for Patients with Multiple Myeloma

Mia Djulbegovic, MD, MS^1,2, Meredith Doherty, PhD, LCSW²^*, Katie Fanslau, DNP, RN²^*, Kan Chen, MA³^*, Sarah Girgis²^*, Pearl Joslyn, BA²^*, Shawn Carney, BS²^*, Joyce Mitchell, MSW, LSW²^*, Abbie Etzweiler, BS²^*, Dan T. Vogl, MD, MSCE², Adam D. Cohen, MD^2,4, Alfred L. Garfall, MD, MTR², Adam Waxman, MD²^*, Sandra Susanibar-Adaniya, MD², Zachary AK Frosch, MD, MSHP⁵, Qi Long, PhD³^*, Karen Glanz, PhD, MPH⁶^* and Edward A. Stadtmauer, MD^2,7

¹Division of Hematology-Oncology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
²Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia
⁴Abramson Cancer Center, The Trustees of The University of Pennsylvania, Philadelphia, PA
⁵Department of Hematology/Oncology; Cancer Prevention and Control Research Program, Fox Chase Cancer Center, Philadelphia, PA
⁶University of Pennsylvania School of Nursing, Philadelphia
⁷Raymond and Ruth Perelman School of Medicine At the University of Pennsylvania, Philadelphia, PA

3:30 PM

910

Comprehensive Analysis of Structural and Social Determinants of Health Leading to Delays in Seeking Hematologic Care: Survey of an Underserved Population with Hematologic Malignancies

Laura Quillen, BS¹, Noura Elsedawy, MD²^*, Terrence Jones, MD², Brion Randolph, MD², Muhammad Saad Hamid, MD² and Swapna Thota, MD^2,3

¹College of Medicine, University of Tennessee Health Science Center, Memphis, TN
²Division of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN
³Department of Medicine, University of Tennessee Health Science Center, MEMPHIS, TN

3:45 PM

911

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Arti Vaishnav, BS¹^*, Abdullah Khan², Qiuhong Zhao, MS²^*, Naresh Bumma, MD³, Francesca Cottini, MD², Elvira Umyarova, MD², Nidhi Sharma, PhD⁴^*, Yvonne Adeduni Efebera, MD, MPH⁵, Lynn O'Donnell, PhD²^*, Ashley E Rosko, MD², Sumithira Vasu, MD, MBBS², Marcos de Lima, MD⁶^*, Don Benson, MD² and Srinivas Devarakonda, MD²

¹The Ohio State University College of Medicine, Columbus, OH
²The Ohio State University, Columbus, OH
³The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
⁴Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
⁵Division of Blood and Marrow Transplant and Cellular Therapy, OhioHealth, Columbus, OH
⁶James Comprehensive Cancer Center, The Ohio State University, Columbus, OH

4:00 PM

912

Incidence of Second Primary Malignancies in Medicare-Insured Patients in the US with Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

Sikander Ailawadhi¹, Thomas Delea²^*, Aaron Moynahan²^*, Wenzhen Ge³^*, Christian Hampp, PhD³^*, Alexi Archambault³^*, Ning Wu³^*, Karen Rodriguez Lorenc³, Irene Noguera-Troise³^*, Glenn S. Kroog³^*, Yariv Houvras³^* and Qiufei Ma³^*

¹Mayo Clinic, Jacksonville, FL
²Policy Analysis Inc., Boston, MA
³Regeneron Pharmaceuticals, Inc., Tarrytown, NY

2:45 PM

907

Clinical Characteristics, Treatment Trends, and Outcomes of Patients with HHV-8-Negative/Idiopathic Multicentric Castleman Disease Treated with Siltuximab in a Machine Learning-Selected Real-World Cohort

Aaron B Cohen, MD^1,2^*, Melissa Estevez, MS³^*, Jonathan G Kelly, MEng³^*, James N Gippetti, MS³^*, Erin L Fidyk, MSN, MBA³^*, Joshua D. Brandstadter, MD, PhD⁴^* and David C. Fajgenbaum, MD, MBA, MSc⁴

¹Flatiron Health, South Orange, NJ
²NYU Grossman School of Medicine, New York, NY
³Flatiron Health, New York, NY
⁴Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

See more of: Oral and Poster Abstracts

<< Previous Session | Next Session >>

^*signifies non-member of ASH

902.O1.6 902. Health Services and Quality Improvement – Lymphoid Malignancies: Improving Processes and Outcomes in Plasma Cell Dyscrasias